GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号：
EP18779782.4
公开号：
EP3692066A2
申请日:
2018.09.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory agent (e.g. an agent directed to ICOS or an anti-CD38 antigen binding protein).
